Sphera Funds Management Ltd. Affimed N.V. Transaction History

Sphera Funds Management Ltd.

  • $545 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$5.37 - $7.07 $6 Million - $7.9 Million
-1,117,619 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$5.54 - $7.51 $881,319 - $1.19 Million
-159,083 Reduced 12.46%
1,117,619 $6.91 Million
Q2 2021

Aug 17, 2021
BUY
$7.78 - $11.4 $2.01 Million - $2.94 Million
257,737 Added 25.29%
1,276,702 $10.9 Million
Q1 2021

May 17, 2021
BUY
$5.12 - $8.48 $5.22 Million - $8.64 Million
1,018,965 New
1,018,965 $8.06 Million

Others Institutions Holding AFMD

# of Institutions
3
Shares Held
1.09M
Call Options Held
0
Put Options Held
0
View Full List

About Affimed N.V.

AFMD Quotes by TradingView
  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $185M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email